Trial intelligence / Profile preview

Efficacy of Gynodian Depot vs Estradiol Valerate in Postmenopausal Women

NCT00463450Phase 3Completed

Sponsor
Bayer
Start
May 2002
Modality
Small Molecules
01

Overview

A Phase 3 trial of prasterone enanthate + estradiol valerate in postmenopause, sponsored by Bayer. Started May 2002; status: completed.

02

Drugs

prasterone enanthate + estradiol valerate
03

Conditions

postmenopause

Beyond the preview

Go deeper on NCT00463450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00463450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call